L T Hamel - Concepedia

Author

L T Hamel

Sterling Research Group (United States)

Also Known As

L Hamel, L T Hamel, Linda Hamel, Linda T. Hamel

Publications

600

Citations

H-Index

Concepts

All Affiliations

Sterling Research Group (United States)South College Sterling Research Group

About

L T Hamel is an author at Sterling Research Group (United States) specializing in medicine, biochemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	372
2	Natural Sciences	2	2	52
3	Health Sciences	1	1	58
4	Social Sciences	1	1	26
5	Applied Physiology	1	1	58

L T Hamel

Publications

571

Citations

H-Index

Page 1

	Year	Citations
Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle Paul J. Silver, L T Hamel, Mark H. Perrone, European Journal of Pharmacology Molecular PharmacologyCardiac MuscleBiochemistryMedicinePhysiology	1988	109
Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone. Paul J. Silver, Rhonda E. Lepore, Brendan O’Connor, Journal of Pharmacology and Experimental Therapeutics	1988	75
Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. Alex L. Harris, B. M. Lemp, Ross Bentley, Journal of Pharmacology and Experimental Therapeutics	1989	61
Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle Paul J. Silver, Alex L. Harris, Paul C. Canniff, Journal of Cardiovascular Pharmacology Cardiac MuscleMuscle FunctionPositive Inotropy MediatedCamp FormationCellular Physiology	1989	58
Phosphodiesterase Isozyme Inhibition, Activation of the cAMP System, and Positive Inotropy Mediated by Milrinone in Isolated Guinea Pig Cardiac Muscle Paul J. Silver, Alex L. Harris, Paul C. Canniff, Journal of Cardiovascular Pharmacology Camp SystemCardiac MuscleCardiomyopathyPhysiological ResearchMolecular Physiology	1989	55
Comparison of Urinary Desmosine Excretion in Patients with Chronic Obstructive Pulmonary Disease or Cystic Fibrosis DC Bode, E D Pagani, WR Cumiskey, Pulmonary Pharmacology & Therapeutics UrologyUrinary Desmosine ExcretionAdvanced Lung DiseasePulmonary FibrosisMedicine	2000	37
Novel and Potent Adenosine 3',5'-Cyclic Phosphate Phosphodiesterase III Inhibitors: Thiazolo[4,5-b][1,6]naphthyridin-2-ones Baldev Singh, Edward R. Bacon, George Y. Lesher, Journal of Medicinal Chemistry Molecular RecognitionMedicinal ChemistryMethyl GroupSecondary Binding SitesBiochemistry	1995	33
The effects of serotonin antagonists in a behavioral despair procedure in mice Daniel Luttinger, Marcia Freedman, L T Hamel, European Journal of Pharmacology PsychopathologyPsychiatryBehavioral NeuroscienceMood SymptomBehavioural Pharmacology	1984	26
Cyclic GMP potentiation by WIN 58237, a novel cyclic nucleotide phosphodiesterase inhibitor. Paul J. Silver, Ronald L. Dundore, D C Bode, Journal of Pharmacology and Experimental Therapeutics	1994	25
Inhibition of low Km cGMP phosphodiesterases and Ca+(+)-regulated protein kinases and relationship to vasorelaxation by cicletanine. Paul J. Silver, Brendan O’Connor, Wayne R. Cumiskey, Journal of Pharmacology and Experimental Therapeutics	1991	24

Page 1